Gns stock forecast short-term gns stock forecast points to

Short-term gns stock forecast points to resistance at $0.68, with support near $0. Additionally, Genus has paid dividends over a period of at least ten years which means that the company is pretty serious about sharing its profits with shareholders. Our latest analyst data shows that the future payout ratio of the company is expected to drop to 35% over the next three years. Accordingly, the expected drop in the payout ratio explains the expected increase in the company's ROE to 12%, over the same period. The overall stock score for Genius Group Limited is low due to significant financial performance challenges, including declining revenues and severe profitability issues. Technical analysis shows mixed signals with potential bearish momentum, and valuation metrics highlight unprofitability. These factors collectively contribute to a low overall stock score. Gns stock forecast from machine learning-driven models indicates high sensitivity to genomics sector news trends, with momentum strengthening when biotech funding announcements hit mainstream media. Short interest ratios have declined, reducing downward pressure risk in upcoming weeks.